Results of an in vivo study on Yi-Gan-San in hTauR406W transgenic flies, a Drosophila AD model with Tau-induced toxicity, showed that Yi-Gan-San can ameliorate AD by decreasing p-Tau expression and alleviating tauopathy (Su et al., 2022). This evidence concerns the gene MAPT and tauopathy.